Rapid resolution of COVID-19 after faecal microbiota transplantation

Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide

(2021) Hsin-Chih Lai et al.   GUT

Alterations in the human oral and gut microbiomes and lipidomics in COVID-19

(2021) Zhigang Ren et al.   GUT

Remdesivir for the Treatment of Covid-19 — Preliminary Report

(2020) John H. Beigel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prolonged presence of SARS-CoV-2 viral RNA in faecal samples

(2020) Yongjian Wu et al.   Lancet Gastroenterology & Hepatology

Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19

(2020) Tao Zuo et al.   GUT

Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study

(2020) Gianluca Ianiro et al.   DIGESTIVE AND LIVER DISEASE

Fecal microbiota transplantation in patients with acute and chronic graft‐versus‐host disease – spectrum of responses and safety profile. Results from a prospective, multicenter study

(2020) Jaroslaw Bilinski et al.   AMERICAN JOURNAL OF HEMATOLOGY

The gut microbiota is associated with immune cell dynamics in humans

(2020) Jonas Schluter et al.   NATURE

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

(2020) Ventura A. Simonovich et al.   NEW ENGLAND JOURNAL OF MEDICINE